{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Rosalind Jenkins"}, {"accession": "MS:1000589", "name": "contact email", "value": "R.Jenkins@liv.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Liverpool"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Rosalind Elspeth Jenkins"}, {"accession": "MS:1000589", "name": "contact email", "value": "R.Jenkins@liv.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "MRC Centre for Drug Safety Science, Dept Molecular & Clinical Pharmacology"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX39-40 260213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX39-40 260213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX41-42 260213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX41-42 260213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX43-44 260213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX43-44 260213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX45-46 260213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX45-46 260213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX47-48 260213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX47-48 260213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX49-50 260213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX49-50 260213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX51-52 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX51-52 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX53-54 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX53-54 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX55-56 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX55-56 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX57-58 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX57-58 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX59-60 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX59-60 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX61-62 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX61-62 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX63-64 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX63-64 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX65-66 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX65-66 270213.wiff.scan"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX67-68 270213.wiff"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX67-68 270213.wiff.scan"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX X15 260213_MGFPeaklist.mgf"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516/GE iTRAQ3 PBMC CLL CEX X15 260213.xml"}], "description": "The mutational status of the immunoglobulin heavy chain variable region (IGHV) defines two clinically distinct forms of chronic lymphocytic leukemia (CLL) known as mutated (M-CLL) and un-mutated (UM-CLL). To elucidate the molecular mechanisms underlying the adverse clinical outcome associated with UM-CLL, total proteomes from 9 UM-CLL and 9 M-CLL samples were analysed by isobaric tags for relative and absolute quantification (iTRAQ)-based mass spectrometry. Unsupervised clustering, based on the expression of 3521 identified proteins, separated CLL samples into two groups corresponding to IGHV mutational status. Computational analysis showed that 43 cell migration/adhesion pathways were significantly enriched by 39 differentially expressed proteins, 35 of which were expressed at significantly lower levels in UM-CLL samples. Furthermore, UM-CLL cells under-expressed proteins associated with cytoskeletal remodelling and over-expressed proteins associated with transcriptional and translational activity. Taken together, our findings indicated that UM-CLL cells are less migratory and more adhesive than M-CLL cells, resulting in their retention in lymph nodes where they are exposed to proliferative stimuli. In keeping with this hypothesis, analysis of an extended cohort of 120 CLL patients revealed a strong and specific association between UM-CLL and lymphadenopathy. Our study illustrates the potential of total proteome analysis to elucidate pathogenetic mechanisms in cancer.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD001516"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD001516"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD001516"}], "instruments": [{"accession": "MS:1000932", "name": "TripleTOF 5600"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Human, iTRAQ, leukemia, mutation"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:01549", "name": "iTRAQ8plex-116 reporter+balance reagent acylated residue"}, {"accession": "MOD:01153", "name": "methylthiolated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "25645933"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Eagle GL, Zhuang J, Jenkins RE, Till KJ, Jithesh PV, Lin K, Johnson GG, Oates M, Park K, Kitteringham NR, Pettitt AR. Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia. Mol Cell Proteomics. 2015 Apr;14(4):933-45"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "CLL iTRAQ3"}